Annovis Bio, Inc. (ANVS)

USD 1.55

(2.65%)

Net Income Summary of Annovis Bio, Inc.

Annovis Bio, Inc.'s latest annual net income in 2023 was -56.2 Million USD , down -123.51% from previous year.
Annovis Bio, Inc.'s latest quarterly net income in 2024 Q1 was -1.06 Million USD , up 95.2% from previous quarter.
Annovis Bio, Inc. reported an annual net income of -25.14 Million USD in 2022, down -74.18% from previous year.
Annovis Bio, Inc. reported an annual net income of -14.43 Million USD in 2021, down -239.11% from previous year.
Annovis Bio, Inc. reported a quarterly net income of -1.06 Million USD for 2024 Q1, up 95.2% from previous quarter.
Annovis Bio, Inc. reported a quarterly net income of -9.53 Million USD for 2023 Q2, up 67.61% from previous quarter.

Annual Net Income Chart of Annovis Bio, Inc. (2023 - 2017)

Historical Annual Net Income of Annovis Bio, Inc. (2023 - 2017)

Year	Net Income	Net Income Growth
2023	-56.2 Million USD	-123.51%
2022	-25.14 Million USD	-74.18%
2021	-14.43 Million USD	-239.11%
2020	-4.25 Million USD	-1334.24%
2019	-296.83 Thousand USD	58.42%
2018	-713.87 Thousand USD	-4.62%
2017	-682.34 Thousand USD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-5.02 Million USD	-370.54%
2024 Q1	-1.06 Million USD	95.2%
2023 Q2	-9.53 Million USD	67.61%
2023 Q3	-14.71 Million USD	-54.31%
2023 FY	-56.2 Million USD	-123.51%
2023 Q1	-29.44 Million USD	-874.77%
2023 Q4	-22.21 Million USD	-50.94%
2022 Q3	-7.51 Million USD	13.07%
2022 Q2	-8.64 Million USD	-47.67%
2022 Q1	-5.85 Million USD	1.01%
2022 FY	-25.14 Million USD	-74.18%
2022 Q4	-3.02 Million USD	59.81%
2021 FY	-14.43 Million USD	-239.11%
2021 Q4	-5.91 Million USD	-107.66%
2021 Q3	-2.84 Million USD	-12.82%
2021 Q2	-2.52 Million USD	21.1%
2021 Q1	-3.19 Million USD	-87.71%
2020 Q4	-1.7 Million USD	-69.39%
2020 Q3	-1 Million USD	56.43%
2020 Q2	-2.3 Million USD	-422.99%
2020 FY	-4.25 Million USD	-1334.24%
2020 Q1	-441.59 Thousand USD	-119.42%
2019 Q1	-190.9 Thousand USD	-13.6%
2019 Q4	-201.25 Thousand USD	20.8%
2019 Q3	-254.12 Thousand USD	26.28%
2019 FY	-296.83 Thousand USD	58.42%
2019 Q2	-344.7 Thousand USD	-80.56%
2018 Q4	-168.05 Thousand USD	-22.01%
2018 FY	-713.87 Thousand USD	-4.62%
2018 Q3	-137.73 Thousand USD	36.86%
2018 Q2	-218.14 Thousand USD	-14.85%
2018 Q1	-189.94 Thousand USD	0.0%
2017 FY	-682.34 Thousand USD	0.0%

Peer Net Income Comparison of Annovis Bio, Inc.

Name	Net Income	Net Income Difference
ADC Therapeutics SA	-240.05 Million USD	76.587%
Alto Neuroscience, Inc.	-36.3 Million USD	-54.811%
Biohaven Pharmaceutical Holding Company Ltd.	-408.16 Million USD	86.23%
Ginkgo Bioworks Holdings, Inc.	-892.86 Million USD	93.705%
Nuvation Bio Inc.	-75.8 Million USD	25.854%
Nuvation Bio Inc.	-75.8 Million USD	25.854%
Arcus Biosciences, Inc.	-307 Million USD	81.692%
Zymeworks Inc.	-118.67 Million USD	52.64%